Please assess the completion status of the following clinical trial:

Trial Title: To Evaluate the Safety of 'Shinbaro Capsule'in Patients With Osteoarthritis

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Minimum 19 years old~* Kellgren stage I \~ III by ACR criteria~* Stable osteoarthritis during 3 months~* Be able to perform WOMAC and KKS~* Written consent form voluntarily~Exclusion Criteria:~* Disease of orthopaedic surgical that could affect to evaluate the efficacy~* Medication of continuous corticosteroid by oral or articular cavity within 12 weeks~* Medication of constantly (more than 1 week) antipsychotic drug or narcotic analgesics within four weeks~* Medical history of hypersensitivity reaction against Herbal drug~* Genetic factors as galactose intolerance, lapplactase deficiency or glucose-galactose malabsorption, etc.~* Occurrence of OA caused by the injury~* Diagnosed with psychical disorder, and taking medication~* Diagnosed with active peptic ulcers, gastrointestinal bleeding, inflammatory bowel disease, severe liver dysfunction, severe renal dysfunction, congestive heart failure, clinically significant ischemic heart disease, peripheral arterial disease, or cerebrovascular diseases~* Diagnosed with esophagus and gastrointestinal ulceration within 1 year, or treated it~* Abnormal bleeding (abnormal of platelet or blood coagulation factor, etc.)~* Positive in fecal occult blood test~* Gastrointestinal tract surgery except appendectomy~* Serum creatinine, ALT, AST, total bilirubin over UNL x 1.5 at screening test~* Participation in another clinical trials within 4 weeks~* Not consent about using effectual contraception method during trial~* Pregnant or lactating woman~* Medical history of malignant tumor within 5 years~* Investigator's judgment

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Shinbaro (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).